AstraZeneca (AZN) Appoints Michel Demare as Incoming Board Chair

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to AstraZeneca (AZN) Appoints Michel Demare as Incoming Board Chair

AstraZeneca (AZN) Tops Q2 EPS by 93c, Beats on Revenue

July 29, 2022 5:58 AM EDT

AstraZeneca (NASDAQ: AZN) reported Q2 EPS of $1.72, $0.93 better than the analyst estimate of $0.79. Revenue for the quarter came in at $10.77 billion versus the consensus estimate of $10.51 billion.

For earnings history and earnings-related data on AstraZeneca (AZN) click here.

... More